Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsTRD care
When depression has not improved enough with standard treatment, Spravato may be considered for eligible adults after clinical evaluation and insurance review.
Multi-location Spravato access across NYC and Long Island, with care-manager support, Medicaid access, and clinic options that account for repeated monitored visits.
Treatment-resistant depression generally refers to depression that has not improved enough after adequate treatment attempts. A Spravato evaluation reviews prior medications, symptom history, safety needs, medical risks, and whether monitored esketamine treatment is appropriate.
Spravato is administered as an intranasal medication under supervision in a certified healthcare setting. Patients are monitored after dosing and need transportation home. Follow-up reviews response, tolerability, scheduling, and whether treatment should continue.
Clinical references reviewed: SPRAVATO REMS and the FDA prescribing information. Last reviewed May 2026. This information does not replace a clinical evaluation.
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens option for patients who want easier access than crossing into Manhattan for every monitored treatment day.
View location detailsBronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for patients who want local Spravato care without leaving the borough.
View location detailsLong Island
232 W Old Country Rd, Hicksville, NY 11801
A central Nassau option for patients who need consistent follow-up, prior auth support, and a shorter commute.
View location detailsQueens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location that helps patients stay on schedule for repeated monitored sessions.
View location detailsQueens
30-07 36th Ave, Astoria, NY 11106
A western Queens access point for patients balancing treatment days with work, home, or Manhattan commutes.
View location detailsLong Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for patients who want strong benefits support and reliable treatment coordination.
View location detailsManhattan
259 1st Ave, New York, NY 10003
A Manhattan Spravato access point for East Village, Gramercy, Kips Bay, and nearby neighborhoods.
View location detailsBrooklyn
308 Graham Ave, Brooklyn, NY 11211
The lead Brooklyn Spravato location for patients who want local access and ongoing psychiatric support.
View location detailsAccepted plans can vary by eligibility and authorization rules. This list reflects the insurance access Nao Medical can review for eligible Spravato patients, including Medicaid, Medicare, Medicare Advantage, and commercial coverage options.
No treatment can be promised as a cure. Spravato may help eligible adults, but response varies and ongoing clinical follow-up is important.
For treatment-resistant depression, Spravato may be used as monotherapy or with an oral antidepressant based on current prescribing information and clinical review.
Response timing varies. For treatment-resistant depression, benefit is commonly reviewed after the initial treatment period and during follow-up visits.
Yes. Therapy and other mental health support may remain part of the care plan when clinically appropriate.